Zydus Cadila gets FDA tentative approval for acne treatment generic

Zydus Cadila has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%.

A generic of Galderma’s Epiduo Forte, Adapalene and Benzoyl Peroxide Gel 0.3%/2.5% is intended for the treatment of acne.

The combination of adapalene and benzoyl peroxide works by destroying the bacteria that cause acne and by helping in the cleaning of the skin pores.

Zydus Cadila gets FDA tentative approval for acne treatment generic — Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%
Zydus Cadila gets FDA tentative approval for acne treatment generic — Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%. Photo courtesy of Zydus Cadila.

Zydus Cadila said that it will manufacture the acne gel at its topical plant in Ahmedabad, India.

The Indian pharma company now has 323 approvals and has to date filed more than 400 abbreviated new drug applications (ANDAs) since the start of the filing process in FY 2003-04.


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

See also  AstraZeneca achieves remarkable financial growth in 2023, fueling optimism for future innovations
Total
0
Shares
Related Posts
Read More

Icosavax, a new vaccine development company, launched in Seattle

Icosavax, a new pharma company, focused on developing vaccines against infectious diseases, has been launched in Seattle, Washington. The vaccine development company is backed by $51 million capital raised through a Series A financing round led by Qiming Venture Partners USA. Other investors in Icosavax are Sanofi Ventures, Adams Street Partners, and NanoDimension, alongside continuing […]

The post Icosavax, a new vaccine development company, launched in Seattle appeared first on PharmaNewsDaily.com.